Best Practice & Research Clinical Haematology
Volume 22, Issue 2 , Pages 223-237 , June 2009

Clinical implications of gene expression profiling in myelodysplastic syndromes: Recognition of ribosomal and translational gene dysregulation and development of predictive assays

  • Naomi Galili, PhD (Associate Professor of Medicine, New York Medical College; Director, Bone Marrow Translational Laboratory)
    • ,
  • Azra Raza, MD (Professor of Medicine, Director, MDS Program)

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +212 604 6029.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00025-5

doi: 10.1016/j.beha.2009.04.006

Best Practice & Research Clinical Haematology
Volume 22, Issue 2 , Pages 223-237 , June 2009

Article Tools

* Image Usage & Resolution